Enzyme Assays
Leverage AI-driven comparisons to identify the best-performing methods from scientific literature, preprints, and patents.
Enhance reproducibility and research accuracy by selecting the most reliable protocols and products.
Streamline your workflow and deliver trustworthy results with PubCompare.ai's data-driven approach to enzyme assay optimization.
Experienece the benefits of this innovative platform today!
Most cited protocols related to «Enzyme Assays»
[22 (link)]. The H2O2 concentration in the assays was far below 1 μM, which leads to a linear concentration/activity response of horseradish peroxidase, which has a KM for H2O2 of 1.55 μM. The high final activity of horseradish peroxidase (7.14 U mL-1) assures a fast conversion of the formed H2O2 and prevents the final reaction to be rate limiting. Additionally, it prevents the accumulation of H2O2, which could have detrimental effects on enzyme stability in the assay. The stability of resorufin fluorescence under these conditions was tested by addition of varying concentrations of hydrogen peroxide (0.1 – 5 μM) to the assay. A stable signal that remained constant throughout the measured period of 45 minutes was observed and maximum signal intensity was reached already during the mixing period before starting the assay. A linear relation between fluorescence and H2O2 concentrations in the range of 0.1 – 2 μM H2O2 was observed and the slope (28450 counts μmol-1) was used for the calculation of an enzyme factor to convert the fluorimeters readout (counts min-1), into enzyme activity. PMO activity was defined as one μmol H2O2 generated per minute under the defined assay conditions.
There were 14 patients lost to follow-up and 5 exitus. Deceased patients were significantly older, had a lower educational level and they also displayed a tendency towards a higher HAQ and DAS28 at baseline than those who finished the follow-up (
Our EAC covers a population of 500,000 inhabitants, >90% of whom are attended by public health insurance. In addition, all primary care physicians in the area are aware of the EAC. To be referred to the clinic, patients must have two or more swollen joints for at least four weeks and symptoms for less than a year. Patients with other specific causes of arthritis were excluded. Thus, only data from patients that fulfilled the ACR criteria for the diagnosis of RA [35] (link) or with chronic undifferentiated arthritis were analyzed. When the 171 patients that fulfilled the two year follow-up were considered, 71% fulfilled the 1987 criteria for RA classification, while 29% remained as undifferentiated arthritis (UA:
The register's protocol included four visits during a follow up period of two years (baseline, 6, 12 and 24 months). At each visit, the following data were collected and entered into an electronic database: clinical and demographic information; disease duration at the beginning of the follow up; 28 tender and swollen joint counts (TJC and SJC, respectively); global disease activity on a 100 mm visual analogue scale assessed both by the patient (GDAP) and the physician (GDAPh); Spanish version of the Health Assessment Questionnaire [36] (link); and laboratory tests including erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) and RF levels assessed by nephelometry (positive>20 UI/ml) and ACPA measured by enzyme immune assay (EIA) (Euro-Diagnostica Immunoscan RA; positive >50 UI/ml).
Most recents protocols related to «Enzyme Assays»
Example 5
Optimizing Inhibitor Cocktail to Maximize Buccal Sample Non-Specific Protease Activity Inhibition
29 inhibitors were tested using a competitive enzymatic activity assay of 3CL protease in buccal samples.
PMSF, GW, aprotinin, eglinC and pepstatin all decreased non-specific protease activity in saliva, with a non significant inhibition of 3CL specific activity.
The four best inhibitors were Eglin C, GW, PMSF and 2,6 PDA.
Various inhibitor cocktails were also tested:
-
- Cocktail 1 (PMSF, GW);
- Cocktail 2 (Eglin C, GW, PMSF and 2,6 PDA)
- Cocktail 2 reduced non-specific proteases to a greater degree than cocktail 1.
Example 12
The ability of these compounds to inhibit the NoV, specifically Minerva virus protease catalytic Cys139 covalently (IC50 and Ki) was determined with an enzyme kinetic assay. NoV strains, specifically GII.4 such as the Minerva virus are responsible for causing the majority (˜80%) of infections in humans. The activity of the inhibitors was evaluated by monitoring the cleavage of a FRET substrate every one minute for 20 minutes (excitation/emission: 488/520 nm) using a SpectraMax M5 microplate reader (Molecular Devices, Sunnyvale CA). Serial dilutions of each inhibitor were incubated with enzyme for 90 minutes at 37° C. before addition of the FRET substrate to ensure complete inactivation. Commercially available protease inhibitors chymostatin and rupintrivir were used as controls.
AGA activity was measured with 1 mM L-aspartic acid β-(7- amido-4-methylcoumarin) in 10% SuperBlock and 90% 50 mM Tris-HC (pH 7.5) for 60 min at 37°C, and then adding 100 µL of stop buffer [0.2 M glycine, 0.175 M NaOH (pH 10.6)], as previously described (Mononen et al., 1993 (link)). GUSB enzyme assay was performed using 10 mM 4-methylumbelliferyl-β-D-glucuronide (Merck) in 0.1 M sodium acetate (pH 4.6) at 37°C for 30 min, and reactions were stopped by 0.1 M sodium carbonate (Grubb et al., 2008 (link)). GAA activity assay was performed with 3 mM 4-methylumbelliferyl-a-D-glucopyranoside (Merck) in assay buffer (30 mM sodium citrate, 40 mM sodium phosphate dibasic, pH 4.0) at 37°C for 3 h (Flanagan et al., 2009 (link)). Reactions were stopped by the addition of an equal volume of 0.4 M glycine, pH 10.8. IDS activity assay was performed with 2.5 mM 4-Methylumbelliferyl sulfate potassium salt (Merck) in 50 mM sodium acetate, at 37°C for 4 h (Dean et al., 2006 (link)). Reactions were stopped with glycine carbonate buffer (pH 10.7). Fluorescence was measured by microplate reader with 360/40 nm excitation and 440/30 nm emission filters.
The pcDNA3.1 plasmid which contains GRP78 lacking its ER retention sequence KDEL was transfected by electroporation as previously described (Trink et al., 2022 (link)). This was used to overexpress GRP78 at the cell surface. The empty vector pcDNA 3.1 was used as a control.
Top products related to «Enzyme Assays»
More about "Enzyme Assays"
These assays leverage AI-driven comparisons to identify the best-performing methods from scientific literature, preprints, and patents.
By enhancing reproducibility and research accuracy, enzyme assays enable researchers to select the most reliable protocols and products, streamlining their workflow and delivering trustworthy results.
The β-Galactosidase Enzyme Assay System is a commonly used assay for measuring the activity of the β-galactosidase enzyme, which is often used as a reporter gene in genetic studies.
ELISA (Enzyme-Linked Immunosorbent Assay) kits are another type of enzyme assay that are widely used for the quantitative measurement of various analytes, including proteins, hormones, and antibodies.
The Complex I Enzyme Activity Microplate Assay Kit is a specialized enzyme assay for measuring the activity of the mitochondrial Complex I enzyme, which is a key component of the electron transport chain.
The Luciferase Assay System, on the other hand, is used to measure the activity of the luciferase enzyme, which is commonly used as a reporter gene in gene expression studies.
Data analysis tools, such as GraphPad Prism, are often utilized in conjunction with enzyme assays to analyze the data and generate visualizations.
Automated laboratory equipment, like the Cobas 8000 and Immulite 2000, can also be employed to streamline the enzyme assay workflow and enhance throughput.
Overall, enzyme assays are a versatile and indispensable tool for researchers across various fields, from biochemistry and molecular biology to drug discovery and development.
By leveraging AI-driven insights and optimizing experimental protocols, researchers can enhance the reproducibility and accuracy of their enzyme assay-based studies, leading to more reliable and impactful findings.